[Incidence of osteodystrophy after transplantation: basic outlines and orthopedic problems].
The generic term "Renal Osteodystrophy" is used to denote a complex of skeletal and metabolic impairments found in nephropathic patients. Neither dialytic treatment nor transplant is always capable of limiting the worsening evolution; transplantation, on the contrary, while it does not in many cases bring the phospho-calcic metabolism back to full normality, introduces new elements of imbalance arising as a result of the inevitable immunosuppressive therapy. After outlining the main post-transplant metabolic problems, the Authors discuss the manifestations of orthopaedic interest, in particular the most severe complication, i.e. aseptic necrosis.
D002762:Cholecalciferol / Q000096:biosynthesis; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000000981:diagnostic imaging / Q000209:etiology* / Q000378:metabolism; D005271:Femur Head Necrosis / Q000209:etiology / Q000601:surgery; D006622:Hip Prosthesis; D006801:Humans; D016030:Kidney Transplantation; D008659:Metabolic Diseases / Q000209:etiology*; D009404:Nephrotic Syndrome / Q000209:etiology / Q000378:metabolism; D010020:Osteonecrosis / Q000000981:diagnostic imaging / Q000209:etiology* / Q000378:metabolism; D010026:Osteosclerosis / Q000209:etiology / Q000378:metabolism; D010281:Parathyroid Hormone / Q000378:metabolism; D011183:Postoperative Complications / Q000209:etiology; D011859:Radiography
D010281:Parathyroid Hormone; D002762:Cholecalciferol
Evoluzione dell'osteodistrofia renale dopo trapianto: lineamenti di base e problemi ortopedici.